Personalis, Inc. (PSNL)
17.08
-1.30
(-7.07%)
USD |
NASDAQ |
Aug 24, 16:00
17.08
0.00 (0.00%)
After-Hours: 20:00
Personalis Price to Book Value : 7.726 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 8.314 |
| August 20, 2026 | 7.635 |
| August 19, 2026 | 7.151 |
| August 18, 2026 | 6.292 |
| August 17, 2026 | 6.283 |
| August 14, 2026 | 6.350 |
| August 13, 2026 | 6.522 |
| August 12, 2026 | 6.427 |
| August 11, 2026 | 6.342 |
| August 10, 2026 | 6.559 |
| August 07, 2026 | 6.405 |
| August 06, 2026 | 5.894 |
| August 05, 2026 | 6.115 |
| August 04, 2026 | 6.115 |
| August 03, 2026 | 5.971 |
| July 31, 2026 | 5.726 |
| July 30, 2026 | 5.554 |
| July 29, 2026 | 5.306 |
| July 28, 2026 | 5.374 |
| July 27, 2026 | 5.419 |
| July 24, 2026 | 5.328 |
| July 23, 2026 | 5.527 |
| July 22, 2026 | 5.640 |
| July 21, 2026 | 6.079 |
| July 20, 2026 | 6.034 |
| Date | Value |
|---|---|
| July 17, 2026 | 6.961 |
| July 16, 2026 | 7.047 |
| July 15, 2026 | 7.142 |
| July 14, 2026 | 6.798 |
| July 13, 2026 | 6.803 |
| July 10, 2026 | 6.364 |
| July 09, 2026 | 6.626 |
| July 08, 2026 | 6.382 |
| July 07, 2026 | 6.323 |
| July 06, 2026 | 6.486 |
| July 02, 2026 | 6.161 |
| July 01, 2026 | 6.237 |
| June 30, 2026 | 6.061 |
| June 29, 2026 | 5.650 |
| June 26, 2026 | 5.350 |
| June 25, 2026 | 5.174 |
| June 24, 2026 | 4.668 |
| June 23, 2026 | 4.134 |
| June 22, 2026 | 4.179 |
| June 18, 2026 | 4.331 |
| June 17, 2026 | 4.007 |
| June 16, 2026 | 3.982 |
| June 15, 2026 | 4.023 |
| June 12, 2026 | 3.941 |
| June 11, 2026 | 3.871 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Tempus AI, Inc. | 26.78 |
| 10X Genomics, Inc. | 10.07 |
| Alamar Biosciences, Inc. (California) | 7.261 |
| Adaptive Biotechnologies Corp. | 28.43 |
| Champions Oncology, Inc. | 17.59 |
Price to Book Value Related Metrics
| PS Ratio | 23.94 |
| Price | 17.08 |
| Earnings Yield | -6.39% |
| Market Cap | 1.817B |